Clinical Trial Update: Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a personalized cancer vaccine immunotherapy in combination with a checkpoint inhibitor for triple-negative breast cancer is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Checkpoint inhibitor
• Personalized cancer vaccine immunotherapy

Snippet

Sponsor: Emory University | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Status: RECRUITING